U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398001) titled 'Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment' on Jan. 20.
Brief Summary: The goal of this clinical trial is to evaluate the benefits and risks of discontinuing antiplatelet therapy on clinical outcomes in patients who previously underwent coronary intervention using a drug-coated balloon.
The main questions it aims to answer are:
Does stopping antiplatelet therapy after 12 months affect the risk of net adverse clinical events? Does stopping antiplatelet therapy reduce the risk of bleeding compared with continuing treatment?
Researchers will compare patients who discontinue antiplatelet therapy with ...